Prevention and management of diabetes in South Asians

Canadian Journal of Diabetes

Volumn 32, Issue 3, 2008, Pages 206-210

  Sohal, Parmjit S ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE   (Canada)

Author keywords

Coronary artery disease; Diabetes; Ethnicity; Impaired glucose tolerance; Metabolic syndrome; Prediabetes; Primary prevention; South Asians

Indexed keywords

ACARBOSE; INSULIN; METFORMIN; ROSIGLITAZONE;

ABDOMINAL OBESITY; ALLOPATHY; BODY MASS; CANADA; DIABETES MELLITUS; DRUG COST; ETHNIC GROUP; GENETIC SUSCEPTIBILITY; GLYCEMIC CONTROL; HEALTH EDUCATION; HERBAL MEDICINE; HUMAN; INCIDENCE; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LIPID STORAGE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRIMARY PREVENTION; REVIEW; SOUTH ASIA; WEIGHT CONTROL;

EID: 53649098447     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-2671(08)23011-X     Document Type: Article

References (41)

1. Statistics Canada 2001 Census: Visible minority population by age group. Available at: http//www40.statcan.ca/L01/cst01/demo50a.htm. Accessed August 15, 2008.
2. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2003;27:S1-S152.
3. American Academy of Physicians of Indian Origin. Available at: http://www.aapimsr.org/Diabetes/diabetesfacts. Accessed August 15, 2008.
4. Sohal P. South Asians: a high risk group. In: Dealing with Difference: Changing the Course of Diabetes. London, UK: Pro-Brook Publishing; 2006:18-19.
5. Davachi S, Flynn MAT, Edwards AL. A health region/community partnership for type 2 diabetes risk factor screening in Indo-Asian communities. Can J Diabetes. 2005;29:87-94.
6. Chowdhury TA. Preventing diabetes in South Asians. BMJ. 2003;327:1059-1060.
7. Egede LE, Dagogo-Jack S. Epidemiology of type 2 diabetes: focus on ethnic minorities. Med Clin North Am. 2005;89:949-975, vii.
8. Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications. Nutrition. 2004;20:482-491.
9. Bajaj M, Banerji MA. Type 2 diabetes in South Asians: a patho-physiologic focus on the Asian-Indian epidemic. Curr Diab Rep. 2004;4:213-218.
10. Gupta M, Brister S. Is South Asian ethnicity an independent cardiovascular risk factor? Can J Cardiol. 2006;22:193-197.
11. Gupta M, Singh N, Verma S. South Asians and cardiovascular risk: what clinicians should know. Circulation. 2006;113:e924-929.
12. Patel K, Minhas R, Gupta S, et al. Managing coronary heart disease in South Asians: meeting the unmet need. Br J Cardiol. 2005;12:200-202.
13. Anand SS, Yusuf S, Vuksan V, et al. Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet. 2000;356:279-284.
14. Razak F, Anand SS, Vuksan V, et al; SHARE Investigators. Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study. Int J Obes (Lond). 2005;29:656-667.
15. Hales CN, Barker DJ. Type 2 (non insulin dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992;35:595-601.
16. Kajantie E, Osmond C, Barker DJ, et al. Size at birth as a predictor of mortality in adulthood: a follow up of 350 000 person years. Int J Epidemiol. 2005;34:655-663.
17. Yajnik CS, Lubree HG, Rege SS, et al. Adiposity and hyperinsulinemia in Indians are preset at birth. J Clin Endocrinol Metab. 2002;314:5575-5580.
18. Abate N, Chandalia M, Snell PG, et al. Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men. J Clin Endocrinol Metab. 2004;89:2750-2755.
19. WHO Expert Consultation. Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-163.
20. Cheng AYY, Leiter LA. Metabolic syndrome under fire: weighing in on the truth. Can J Cardiol. 2006;22:379-382.
21. International Diabetes Federation. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Available at: http://www.idf.org/ webdata/docs/IDF_Meta_def_final.pdf. Accessed August 15, 2008.
22. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350.
23. Knowler WC, Barrett-Conner E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
24. Chiasson JL, Josse RG, Gomis R, et al; STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA. 2003;290:486-494.
25. Knowler WC, Hamman RF, Edelstein SL, et al; Diabetes Prevention Program Research Group. Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes. 2005;54:1150-1156.
26. The DREAM (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators; Gerstein HC, Yusuf S, Bosch J, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. Lancet. 2006;368:1096-1105.
27. Ramachandran A, Snehalatha C, Mary S, et al; Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49:289-297.
28. Diabetes Prevention Program Research Group. Strategies to identify adults at high risk for type 2 diabetes. Diabetes Care. 2005;28:138-144.
29. Anand SS, Razak F, Vuksan V, et al. Diagnostic strategies to detect glucose intolerance in a multiethnic population. Diabetes Care. 2003;26:290-296.
30. Jafar TH, Chaturvedi N, Pappas G. Prevalence of overweight and obesity and their association with hypertension and diabetes mellitus in an Indo-Asian population. CMAJ. 2006; 175:1071-1077.
31. O'Hare JP, Raymondt NT, Mughal S, et al; UKADS Study Group. Evaluation of delivery of enhanced diabetes care to patients of South Asian ethnicity: the United Kingdom Asian Diabetes Study (UKADS). Diabet Med. 2004;21:1357-1365.
32. Barnett AH, Grant PJ, Hitman GA, et al; Indo-Asian Trial Investigators. Rosiglitazone in type 2 diabetes mellitus: an evaluation in British Indo-Asian patients. Diabet Med. 2003; 20:387-390.
33. Leiter LA, Genest J, Harris SB, et al. Dyslipidemia in adults with diabetes. Can J Diabetes. 2006;30:230-240.
34. Deedwania PC, Gupta M, Stein M, et al; IRIS Study Group. Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS trial). Am J Cardiol. 2007;99:1538-1543.
35. Macaden L. Variation in risk perception: South Asians living in the UK and their healthcare professionals. Diabetes Voice. 2007; 52:13-16.
36. Baradaran H, Knill-Jones R. Assessing the knowledge, attitudes and understanding of type 2 diabetes amongst ethnic groups in Glasgow, Scotland. Pract Diabet Int. 2004;21:143-148.
37. Lawton J, Ahmad N, Hanna L, et al. "I can't do any serious exercise": barriers to physical activity amongst people of Pakistani and Indian origin with type 2 diabetes. Health Educ Res. 2006;21:43-54.
38. Naeem AG. The role of culture and religion in the management of diabetes: a study of Kashmiri men in Leeds. J R Soc Health. 2003;123:110-116.
39. Mukhopadhyay BN, Forouhi NG, Fisher BM, et al. A comparison of glycemic and metabolic control over time among South Asian and European patients with type 2 diabetes: results from follow-up in a routine diabetes clinic. Diabet Med. 2005; 23:94-98.
40. McElduff P, Edwards R, Burns JA, et al. Comparison of processes and intermediate outcomes between South Asian and European patients with diabetes in Blackburn, north-west England. Diabet Med. 2005;22:1226-1233.
41. Vyas A, Haidery AZ, Wiles PG, et al. A pilot randomized trial in primary care to investigate and improve knowledge, awareness and self-management among South Asians with diabetes in Manchester. Diabet Med. 2003;20:1022-1026.